0.65 USD
▼+0.00-0.35%
盘后 0.64 -2.03%
2026-08-03
市值
$3.94M
市盈率
—
EPS
-0.14
股息率
—
52 周区间
0.63 – 2.79
成交量
18.41K
Beta
4.97
目标价
—
52W 低 0.6352W 高 2.79
价格走势
公司简介
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers’ diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection; and host directed anti-viral; ...